Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2026-08-28 16:11:39 ET · period of report 2026-08-26 · accession 0001695028-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-28 16:11 | 2026-08-26 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $4.89 | +77.0K | 146.8K | +110% | +$376.7K |
| DT | 2026-08-28 16:11 | 2026-08-26 | ORIC | Piscitelli Dominic | CFO | S - Sale+OE | $13.69 | -77.0K | 69.8K | -52% | -$1.05M |
| DMT | 2026-08-28 16:11 | 2026-08-26 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $0.00 | -77.0K | 120.0K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-26 | M | A | 52,000 | $4.36 | 121,828 | D | — | — | (F1) Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-08-26 | M | A | 25,000 | $6.00 | 146,828 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-26 | S | D | 77,000 | $13.69 | 69,828 | D | — | — | (F2) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026. |
| 4 | Derivative | Stock Option (right to buy) | 2026-08-26 | M | D | 52,000 | $0.00 | 92,500 | D | $4.36 · 2025-07-20 to 2032-07-19 | 52,000 Common Stock | |
| 5 | Derivative | Stock Option (right to buy) | 2026-08-26 | M | D | 25,000 | $0.00 | 120,000 | D | $6.00 · — to 2033-01-31 | 25,000 Common Stock | (F3) 25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter. |